Augmentation ciblée de la production de gènes nucléaires

Targeted augmentation of nuclear gene output

Abstract

La présente invention concerne des procédés et des compositions destinés à l'augmentation de la production d'une protéine cible ou d'un ARN fonctionnel par une cellule.
Provided herein are methods and compositions for increasing production of a target protein or functional RNA by a cell.

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (0)

    Publication numberPublication dateAssigneeTitle

NO-Patent Citations (4)

    Title
    FRIEDMAN, KJ ET AL.: "Correction of Aberrant Splicing of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene by Antisense Oligonucleotides.", J. BIOL. CHEM., vol. 274, no. 51, 17 December 1999 (1999-12-17), pages 36193 - 36199, XP002589149, DOI: doi:10.1074/jbc.274.51.36193
    KRALOVICOVA, J ET AL.: "Optimal Antisense Target Reducing INS Intron 1 Retention is Adjacent to a Parallel G Quadruplex.", NUCLEIC ACIDS RESEARCH, vol. 42, no. 12, 17 June 2014 (2014-06-17), pages 8161 - 8173, XP055211568, DOI: doi:10.1093/nar/gku507
    RENDU, J ET AL.: "Exon Skipping As A Therapeutic Strategy Applied To An RYR1 Mutation With Pseudo-Exon Inclusion Causing A Severe Core Myopathy.", HUMAN GENE THERAPY., vol. 21, July 2013 (2013-07-01), pages 702 - 713
    SIERAKOWSKA, H ET AL.: "Repair Of Thalassemic Human Beta-lobin mRNA In Mammalian Cells By Antisense Oligonucleotides.", PROC. NATL. ACAD. SCI. USA., vol. 93, November 1996 (1996-11-01), pages 12840 - 12844

Cited By (0)

    Publication numberPublication dateAssigneeTitle